Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 4.000
+0.070 (1.78%)
Jan 30, 2026, 12:38 PM AEST
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 199.51 million as of January 29, 2026.
Market Cap
199.51M
Enterprise Value
172.21M
Revenue
1.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.00
Market Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 199.51M, an increase of 31.25%. That is a compound annual growth rate of 59.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 199.51M | 20.85% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dimerix | 315.21M |
| Orthocell | 260.46M |
| Botanix Pharmaceuticals | 226.56M |
| Recce Pharmaceuticals | 186.52M |
| Actinogen Medical | 153.20M |
| Paradigm Biopharmaceuticals | 143.05M |
| Starpharma Holdings | 142.77M |
| Proteomics International Laboratories | 106.57M |